Newmont Corporation (BMV:NEM)

Verve Therapeutics Statistics

Total Valuation

Newmont has a market cap or net worth of MXN 1.30 trillion. The enterprise value is 1.31 trillion.

Market Cap	1.30T
Enterprise Value	1.31T

Important Dates

The last earnings date was Thursday, July 24, 2025.

Earnings Date	Jul 24, 2025
Ex-Dividend Date	May 27, 2025

Share Statistics

Current Share Class	1.10B
Shares Outstanding	n/a
Shares Change (YoY)	+10.83%
Shares Change (QoQ)	-1.33%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.10B

Valuation Ratios

The trailing PE ratio is 10.99 and the forward PE ratio is 14.52.

PE Ratio	10.99
Forward PE	14.52
PS Ratio	3.35
PB Ratio	2.14
P/TBV Ratio	2.34
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.88, with an EV/FCF ratio of 13.08.

EV / Earnings	11.09
EV / Sales	3.37
EV / EBITDA	5.88
EV / EBIT	8.36
EV / FCF	13.08

Financial Position

The company has a current ratio of 2.23, with a Debt / Equity ratio of 0.24.

Current Ratio	2.23
Quick Ratio	1.56
Debt / Equity	0.24
Debt / EBITDA	0.66
Debt / FCF	1.43
Interest Coverage	24.89

Financial Efficiency

Return on equity (ROE) is 20.28% and return on invested capital (ROIC) is 12.77%.

Return on Equity (ROE)	20.28%
Return on Assets (ROA)	9.07%
Return on Invested Capital (ROIC)	12.77%
Return on Capital Employed (ROCE)	15.92%
Revenue Per Employee	17.49M
Profits Per Employee	5.33M
Employee Count	22,200
Asset Turnover	0.37
Inventory Turnover	4.13

Taxes

In the past 12 months, Newmont has paid 50.63 billion in taxes.

Income Tax	50.63B
Effective Tax Rate	29.97%

Stock Price Statistics

The stock price has increased by +35.43% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+35.43%
50-Day Moving Average	1,096.29
200-Day Moving Average	966.07
Relative Strength Index (RSI)	57.54
Average Volume (20 Days)	751

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.52

Income Statement

In the last 12 months, Newmont had revenue of MXN 388.18 billion and earned 118.37 billion in profits. Earnings per share was 104.74.

Revenue	388.18B
Gross Profit	216.19B
Operating Income	151.64B
Pretax Income	168.93B
Net Income	118.37B
EBITDA	206.27B
EBIT	151.64B
Earnings Per Share (EPS)	104.74

Balance Sheet

The company has 125.46 billion in cash and 143.45 billion in debt, giving a net cash position of -8.26 billion.

Cash & Cash Equivalents	125.46B
Total Debt	143.45B
Net Cash	-8.26B
Net Cash Per Share	n/a
Equity (Book Value)	608.87B
Book Value Per Share	550.02
Working Capital	108.04B

Cash Flow

In the last 12 months, operating cash flow was 161.69 billion and capital expenditures -61.33 billion, giving a free cash flow of 100.36 billion.

Operating Cash Flow	161.69B
Capital Expenditures	-61.33B
Free Cash Flow	100.36B
FCF Per Share	n/a

Margins

Gross margin is 55.69%, with operating and profit margins of 39.06% and 30.49%.

Gross Margin	55.69%
Operating Margin	39.06%
Pretax Margin	43.52%
Profit Margin	30.49%
EBITDA Margin	53.14%
EBIT Margin	39.06%
FCF Margin	25.86%

Dividends & Yields

This stock pays an annual dividend of 20.03, which amounts to a dividend yield of 1.69%.

Dividend Per Share	20.03
Dividend Yield	1.69%
Dividend Growth (YoY)	-10.69%
Years of Dividend Growth	n/a
Payout Ratio	17.99%
Buyback Yield	-10.83%
Shareholder Yield	-9.14%
Earnings Yield	9.10%
FCF Yield	7.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Newmont has an Altman Z-Score of 2.44 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.44
Piotroski F-Score	8